SHIRAKAWA Toshiro

J-GLOBAL         Last updated: Apr 11, 2019 at 15:16
 
Avatar
Name
SHIRAKAWA Toshiro
Affiliation
Kobe University
Section
Graduate School of Science, Technology and Innovation Department of Science, Technology and Innovation
Job title
Professor

Awards & Honors

 
Jun 2017
Anti-tumor immune responses induced by oral cancer vaccine using recombinant Bifidobacterium displaying Wilms’ tumor 1 protein, 第21回腸内細菌学会 最優秀発表賞, 日本ビフィズス菌センター/腸内細菌学会
Winner: 辰巳 真帆, KITAGAWA KOICHI, 五ノ井 玲菜, 斉藤 大樹, 橋井 佳子, 片山 高嶺, SHIRAKAWA TOSHIRO
 
Jun 2008
学会発表演題, 第13回JSGT学会賞, 日本遺伝子治療学会
 
Aug 2006
命にかかわる下痢性感染症予防のための水質汚染モニタリング法の開発, クリタ水・環境科学振興財団 研究助成金, (財)クリタ水・環境科学振興財団
Winner: SHIRAKAWA TOSHIRO
 
2004
腫瘍特異的増殖型アデノウイルスおよびキャリアー細胞を用いた前立腺癌に対する遺伝子治療法の開発, 前立腺研究財団優秀研究課題受賞, 前立腺研究財団
 

Published Papers

 
Kitagawa K, Shigemura K, Yamamichi F, Osawa K, Uda A, Koike C, Tokimatsu I, Shirakawa T, Miyara T, Fujisawa M
International journal of urology : official journal of the Japanese Urological Association   26(3) 358-362   Mar 2019   [Refereed]
Shirakawa T, Kitagawa K, Tatsumi M, Gonoi R, Katayama T, Hashii Y, Fujisawa M, Kadowaki M
Molecular cancer therapeutics      Mar 2019   [Refereed]
Yoneda T, Kunimura N, Kitagawa K, Fukui Y, Saito H, Narikiyo K, Ishiko M, Otsuki N, Nibu KI, Fujisawa M, Serada S, Naka T, Shirakawa T
Cancer gene therapy      Jan 2019   [Refereed]
Mita Y, Shigemura K, Osawa K, Kitagawa K, Kotaki T, Shirakawa T, Miyara T, Fujisawa M
Urologia internationalis   102(2) 205-211   2019   [Refereed]
Osawa K, Shigemura K, Kitagawa K, Fukuda T, Takasaka A, Wakabayashi S, Sato K, Yamamichi F, Shirakawa T, Fujisawa M
International journal of urology : official journal of the Japanese Urological Association      Oct 2018   [Refereed]
Kuntaman K, Shigemura K, Osawa K, Kitagawa K, Sato K, Yamada N, Nishimoto K, Yamamichi F, Rahardjo D, Hadi U, Mertaniasih NM, Kinoshita S, Fujisawa M, Shirakawa T
International journal of urology : official journal of the Japanese Urological Association      Sep 2018   [Refereed]
Nakanishi N, Nomoto R, Sato K, Koike C, Kusuki M, Nakamura T, Shigemura K, Shirakawa T, Fujisawa M, Tokimatsu I, Osawa K
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy      Aug 2018   [Refereed]
Kusuki M, Osawa K, Arikawa K, Tamura M, Shigemura K, Shirakawa T, Nakamura T, Nakamachi Y, Fujisawa M, Saegusa J, Tokimatsu I
Diagnostic microbiology and infectious disease   91(3) 256-259   Jul 2018   [Refereed]
Kojima Y, Otsuki N, Kubo M, Kitamoto J, Takata E, Saito H, Kosaka K, Morishita N, Uehara N, Shirakawa T, Nibu KI
Cancer gene therapy   25(9-10) 274-283   May 2018   [Refereed]
Kitagawa K, Shigemura K, Onuma KI, Nishida M, Fujiwara M, Kobayashi S, Yamasaki M, Nakamura T, Yamamichi F, Shirakawa T, Tokimatsu I, Fujisawa M
J Clin Lab Anal.   32(3) e22301   Mar 2018   [Refereed]
Shirakawa T, Kitagawa K
Hum Vaccin Immunother   14(1) 159-162   Jan 2018   [Refereed]
Kitagawa K, Shigemura K, Yamamichi F, Alimsardjono L, Rahardjo D, Kuntaman K, Shirakawa T, Fujisawa M
Jpn J Infect Dis.   71(1) 8-13   Jan 2018   [Refereed]
Osawa K, Shigemura K, Nukata Y, Kitagawa K, Yamamichi F, Yoshida H, Shirakawa T, Arakawa S, Fujisawa M
Antimicrobial agents and chemotherapy   61(8)    Aug 2017   [Refereed]
Bagus Wasito E, Shigemura K, Osawa K, Fardah A, Kanaida A, Raharjo D, Kuntaman K, Hadi U, Harijono S, Marto Sudarmo S, Nakamura T, Shibayama K, Fujisawa M, Shirakawa T
Japanese journal of infectious diseases   70(4) 378-382   Jul 2017   [Refereed]
WasitoEB, SHIGEMURA KATSUMI, OSAWA KAYO, FardahA, KanaidaA, RaharjoD, KuntamanK, HadiU, HarijonoS, SudarmoSM, NakamuraT, ShibayamaK, FujisawaM, ShirakawaT
Jpn J Infect Dis.   70(4) 378-382   Jul 2017   [Refereed]
Combination of p53-DC vaccine and rAd-p53 gene therapy induced CTLs cytotoxic against p53-deleted human prostate cancer cells in vitro
SaitoH, KitagawaK, YonedaT, FukuiY, FujsawaM, BautistaD, Shirakawa Toshiro
Cancer Gene Ther   24(7) 289-296   Jul 2017   [Refereed]
Osawa K, Shigemura K, Nukata Y, Kitagawa K, Yamamichi F, Yoshida H, Shirakawa Toshiro, Arakawa S, Fujisawa Masato
Antimicrob Agents Chemother.   61(8) pii: e01174-17.   Jul 2017   [Refereed]
Kitagawa K, Oda T, Saito H, Araki A, Gonoi R, Shigemura K, Hashii Y, Katayama T, Fujisawa M, Shirakawa T
Cancer immunology, immunotherapy : CII   66(6) 787-798   Jun 2017   [Refereed]
Kitagawa Koichi, Omoto Chika, Oda Tsugumi, Araki Ayame, Saito Hiroki, Shigemura Katsumi, Katayama Takane, Hotta Hak, Shirakawa Toshiro
Viral Immunol   30(3) 196-203   Apr 2017   [Refereed]
OSAWA RO, OSAWA KAYO, SHIRAKAWA TOSHIRO
Japanese Journal of Infectious Diseases   70(1) 80-83   Jan 2017   [Refereed]
Diarrheagenic Escherichia coli (DEC) is an important agent of endemic and epidemic diarrhea worldwide, particularly in developing countries. DEC cannot be differentiated from commensal E. coli on selective media, although there are a few exception...

Misc

 
【C型肝炎治療update】 基礎研究の進歩 ビフィズス菌を利用したC型肝炎経口ワクチンの開発(解説/特集)
Shirakawa Toshiro
日本臨床   73(2) 239-242   Feb 2014
Shigemura K, Tanaka K, Matsumoto M, Nakano Y, Shirakawa T, Miyata M, Yamashita M, Arakawa S, Fujisawa M
J Infect Chemother   Vol 19. No. 4, pp. 479-84    Aug 2012   [Refereed]
Shirakawa Toshiro
Drug news & perspectives   Vol. 22, No. 3, pp. 140-5    Apr 2009   [Refereed]
【がん化学療法個別化の現状と展望】 泌尿器科腫瘍の遺伝子診断と個別化治療を目指した分子標的療法
Shirakawa Toshiro
医薬ジャーナル   44巻, 12号, pp. 83-86    Dec 2008
The current status of adenovirus-based cancer gene therapy
Shirakawa Toshiro
Molecules and cells   Vol. 25, No. 4, pp. 462-6    Jun 2008   [Refereed]

Books etc

 
先端治療技術の実用化と開発戦略
SHIRAKAWA TOSHIRO, KITAGAWA KOICHI
(株)技術情報協会   Apr 2017   
第7章 経口ワクチン
SHIRAKAWA TOSHIRO
株式会社 情報機構   Oct 2013   
Cancer Gene Therapy / 14.Current therapeutic strategies in gene therapy for prostate cancer
Shirakawa Toshiro (Part:Joint Work)
Research Signpost   Jan 2010   
Welcome to ゲノムワールド / 5-3 遺伝子治療 5-4 再生医療
Shirakawa Toshiro (Part:Joint Work)
廣川書店   Oct 2009   
Gene Therapy 2007 / Gene Therapy in prostate cancer: past, present and future
SHIRAKAWA TOSHIRO, FUJISAWA MASATO (Part:Joint Work)
21st Century's Center of Excellence Program of Japanese Ministry of Education and Science   Jan 2007   

Conference Activities & Talks

 
Analysis of antimicrobial resistance mechanism in successive infections of Pseudomonas aeruginosa
Noriko Nakanishi, Ryohei Nomoto, Kanako Sato, Chihiro Koike, Mari Kusuki, Tatsuya Nakamura, Shigemura Katsumi, Shirakawa Toshiro, Tokimatsu Issei, Osawa Kayo
第91回日本細菌学会総会   Mar 2018   
Anti-tumor effect and suppression of immune escapeby adenovirus carrying SOCS3 gene in prostate cancer
米田 智美, 斉藤 大樹, 福井 悠夏, 北川 孝一, 世良田 聡, 仲 哲治, Shirakawa Toshiro
第40回日本分子生物学会年会   Dec 2017   The Molecular Biology Society of Japan
Anti-tumor effect against prostate cancer induced by oral cancer vaccine using recombinant Bifidobacterium displaying Wilms' tumor 1 protein in mice
五ノ井 玲菜, 北川 孝一, 古田 拓也, 辰巳 真帆, 斉藤 大樹, 橋井 佳子, 片山 高嶺, Shirakawa Toshiro
第40回日本分子生物学会年会   Dec 2017   The Molecular Biology Society of Japan
Development of novel oral cancer vaccine using Bifidobacterium [Invited]
Shirakawa Toshiro
Hwasun Adenoviral Cancer Therapeutics Symposium   Sep 2017   Chonnam National University
Enhanced anti-tumor effect by combining oral cancer vaccine using Bifidobacterium displaying WT1 protein with anti-PD-1 antibody therapy in mouse prostate cancer model.
北川 孝一, 斉藤 大樹, 五ノ井 玲菜, 辰巳 真帆, 古田 拓也, 橋井 佳子, 片山 高嶺, Shirakawa Toshiro
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference   Sep 2017   

Teaching Experience

 

Patents

 
9925259 : 免疫原性ポリペプチド表層発現ビフィズス菌(米国)
SHIRAKAWA TOSHIRO, 堀田 博, 片山 高嶺
特許6213969 : 免疫原性ポリペプチド表層発現ビフィズス菌
SHIRAKAWA TOSHIRO, HOTTA HAK, 片山 高嶺
特許5582542 : 腫瘍免疫誘導剤
SHIRAKAWA TOSHIRO, 斎藤 彩, 松岡 孝幸
特許5561681 : ビフィズス菌表層提示融合タンパク質発現遺伝子
SHIRAKAWA TOSHIRO, 山本 さくら
特許5187642 : 経口ワクチン
SHIRAKAWA TOSHIRO, KAWABATA MASATO, 高田 哲男, 谷口 道子, 岡本 明子